Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole

This study has been completed.
Sponsor:
Collaborator:
Sanofi
Information provided by:
Drugs for Neglected Diseases
ClinicalTrials.gov Identifier:
NCT00982904
First received: September 22, 2009
Last updated: March 9, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)